News from mimedx group, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 23, 2015, 17:45 ET

Government Declines to Intervene in Action Against MiMedx

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Mar 17, 2015, 11:11 ET

MiMedx to Present at 3rd Annual Regen Med Investor Day

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Mar 16, 2015, 15:19 ET

MiMedx To Present At Canaccord's 10th Annual Musculoskeletal Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Feb 26, 2015, 07:30 ET

MiMedx Announces 2014 Record Revenue and First Full Year Operating Profit

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Feb 04, 2015, 08:52 ET

MiMedx Announces Release Date For 2014 Full Year Results

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes...

Feb 03, 2015, 09:00 ET

MiMedx Withdraws Complaint Against Organogenesis Without Prejudice To Focus On Investigation

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jan 12, 2015, 08:45 ET

MiMedx Announces over 30 National Account Contracts

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jan 12, 2015, 08:15 ET

MiMedx Exceeds Fourth Quarter And Full Year 2014 Revenue Forecasts

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jan 06, 2015, 11:35 ET

MiMedx Announces $10 Million Increase to Stock Repurchase Program

 MiMedx Group, Inc.  (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected...

Dec 31, 2014, 16:15 ET

MiMedx Announces Receipt Of Civil Subpoena

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 31, 2014, 16:05 ET

MiMedx Files Tortious Interference Lawsuit Against Organogenesis

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 30, 2014, 17:00 ET

MiMedx Comments On Recent FDA Draft Guidance On Minimal Manipulation Of HCT/Ps

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 22, 2014, 14:28 ET

MiMedx To Present At 33rd Annual J.P. Morgan Healthcare Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 15, 2014, 08:45 ET

MiMedx Raises Expectations For 2015 Revenue To Range From $175 Million To $190 Million

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 04, 2014, 09:00 ET

MiMedx To Present At The Oppenheimer 25th Annual Healthcare Conference

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 18, 2014, 08:00 ET

Thirteen Poster Abstracts Chronicling The Clinical Use, Cost Effectiveness And Accelerated Healing Results of MiMedx Products to be Presented by VA Physicians at Desert Foot Conference

 MiMedx Group, Inc. (NASDAQ: MDXG) announced today that fourteen poster abstracts chronicling the Company's dehydrated human...

Nov 17, 2014, 16:01 ET

Multi-Center Comparative Study Of MiMedx EpiFix® And Organogenesis Apligraf® Determines EpiFix Has Considerably Higher Rates Of Complete Healing And Significantly Faster Time To Heal

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 07, 2014, 09:39 ET

MiMedx® Adds New Executive

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 05, 2014, 14:59 ET

MiMedx To Present At Two Healthcare Conferences

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Oct 30, 2014, 07:30 ET

MiMedx Achieves Record Revenue And Records First Operating Profit

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...